question 14 dr. parma is conducting a clinical trial on the efficacy of a new psychiatric medication to…

question 14 dr. parma is conducting a clinical trial on the efficacy of a new psychiatric medication to treat schizophrenia. her clinical patients (those who received the drug) reported significantly fewer symptoms after three months of treatment than her control participants did. however, her colleagues did not find the same pattern when they repeated the trial with a new set of patients. what is the most likely explanation for this? a. dr. parma underreported a null effect. b. dr. parma obtained a false - positive. c. dr. parma engaged in questionable research practices. d. dr. parma is guilty of harking.

question 14 dr. parma is conducting a clinical trial on the efficacy of a new psychiatric medication to treat schizophrenia. her clinical patients (those who received the drug) reported significantly fewer symptoms after three months of treatment than her control participants did. however, her colleagues did not find the same pattern when they repeated the trial with a new set of patients. what is the most likely explanation for this? a. dr. parma underreported a null effect. b. dr. parma obtained a false - positive. c. dr. parma engaged in questionable research practices. d. dr. parma is guilty of harking.

Answer

Brief Explanations:

Dr. Parma's patients reported a positive effect while others didn't. This could be due to researcher - related bias. If Dr. Parma had high expectations for the drug's efficacy, she might have unconsciously influenced her patients or the data collection process. False positives can occur when researchers' expectations affect the results.

Answer:

B. Dr. Parma obtained a false positive.